1 |
Kurlansik SL, Maffei MS. Somatic symptom disorder. Am Fam Physician. 2016;93(1):49-54.
|
2 |
Dhond RP, Kettner N, Napadow V. Neuroimaging acupuncture effects in the human brain. J Altern Complement Med. 2007;13(6):603-16.
DOI
|
3 |
Vargas-Prada S, Coggon D. Psychological and psychosocial determinants of musculoskeletal pain and associated disability. Best Pract Res Clin Rheumatol. 2015; 29(3):374-90.
DOI
|
4 |
Yu SH, Park JM, Hong HP. The effects the application of myofascial release of depression, anxiety, sleep disturbance, and headache in post traumatic stress disorder patients with somatization: case study. The Journal of Korean of Orthopedic Manual Physical Therapy. 2017;23(2):75-81.
|
5 |
Sochos A, Bennett A. Psychological distress, physical symptoms, and the role of attachment style in acupuncture. Altern Ther Health Med. 2016;22(3):8-16.
|
6 |
Yamaguchi T, Tsujimatsu A, Kumamoto H, Izumi T, Ohmura Y, Yoshida T, Yoshioka M. Anxiolytic effects of yokukansan, a traditional Japanese medicine, via serotonin 5-HT1A receptors on anxiety-related behaviors in rats experienced aversive stress. J Ethnopharmacol. 2012;143(2):533-9.
DOI
|
7 |
Lee EH, Lee SJ, Hwang ST, Hong SH, Kim JH. Reliability and validity of the Beck Depression Inventory-II among Korean adolescents. Psychiatry Investig. 2017;14(1):30-6.
DOI
|
8 |
Liao SC, Huang WL, Ma HM, Lee MT, Chen TT, Chen IM, Gau SS. The relation between the patient health questionnaire-15 and DSM somatic diagnoses. BMC Psychiatry. 2016;16(1):351.
DOI
|
9 |
Lamahewa K, Buszewicz M, Walters K, Marston L, Nazareth I. Persistent unexplained physical symptoms: a prospective longitudinal cohort study in UK primary care. Br J Gen Pract. 2019;69(681):246-53.
DOI
|
10 |
Outram S, Murphy B, Cockburn J. The role of GPs in treating psychological distress: a study of midlife Australian women. Fam Pract. 2004;21(3):276-81.
DOI
|
11 |
Rosendal M, Blankenstein AH, Morriss R, Fink P, Sharpe M, Burton C. Enhanced care by generalists for functional somatic symptoms and disorders in primary care. Cochrane Database Syst Rev. 2013;(10):CD008142.
|
12 |
Konnopka A, Kaufmann C, Konig HH, Heider D, Wild B, Szecsenyi J, Herzog W, Heinrich S, Schaefert R. Association of costs with somatic symptom severity in patients with medically unexplained symptoms. J Psychosom Res. 2013;75:370-5.
DOI
|
13 |
Dimsdale JE, Creed F, Escobar J, Sharpe M, Wulsin L, Barsky A, Lee S, Irwin MR, Levenson J. Somatic symptom disorder: an important change in DSM. J Psychosom Res. 2013;75(3):223-8.
DOI
|
14 |
American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 5th ed. Washington, DC:American Psychiatric Association. 2013.
|
15 |
Hartman TC, Borghuis MS, Lucassen PL, van de Laar FA, Speckens AE, van Weel C. Medically unexplained symptoms, somatisation disorder and hypochondriasis: course and prognosis. A systematic review. J Psychosom Res. 2009;66(5):363-77.
DOI
|
16 |
Somashekar B, Jainer A, Wuntakal B. Psychopharmacotherapy of somatic symptoms disorders. Int Rev Psychiatry. 2013;25(1):107-15.
DOI
|
17 |
Karcioglu O, Topacoglu H, Dikme O, Dikme O. A systematic review of the pain scales in adults: which to use? Am J Emerg. 2018;36(4):707-14.
DOI
|
18 |
Julian LJ. Measures of anxiety: State-Trait Anxiety Inventory (STAI), Beck Anxiety Inventory (BAI), and Hospital Anxiety and Depression Scale-Anxiety (HADS-A). Arthritis Care Res (Hoboken). 2011;63:467-72.
DOI
|
19 |
Levis B, Benedetti A, Thombs BD; DEPRESsion Screening Data (DEPRESSD) Collaboration. Accuracy of Patient Health Questionnaire-9 (PHQ-9) for screening to detect major depression: individual participant data meta-analysis. BMJ. 2019;365:1476.
|
20 |
Lins L, Carvalho FM. SF-36 total score as a single measure of health-related quality of life: scoping review. SAGE Open Med. 2016;4:2050312116671725.
DOI
|